id: NEW:injecting_drug_use_prevalence_to_liver_failure_cirrhosis_hospitalization
name: Injecting Drug Use Prevalence â†’ Liver Disease Hospitalization
from_node:
  node_id: NEW:injecting_drug_use_prevalence
  node_name: Injecting Drug Use Prevalence
to_node:
  node_id: liver_failure_cirrhosis_hospitalization
  node_name: Liver Disease Hospitalization
direction: positive
category: behavioral
mechanism_pathway:
- 'Step 1: Injecting drug use involves sharing of needles and drug preparation equipment,
  creating direct blood-to-blood contact between users'
- 'Step 2: Blood-borne hepatitis C virus (HCV) transmission occurs through contaminated
  injection equipment, with HCV seroprevalence reaching 20% (95% CI 12%-30%) among
  people who are homeless with injection drug use'
- 'Step 3: Chronic HCV infection leads to progressive liver inflammation and hepatic
  fibrosis, with F4 fibrosis (cirrhosis) prevalence of 7-16% in this population'
- 'Step 4: Advanced liver fibrosis and cirrhosis result in liver decompensation requiring
  hospitalization for complications including liver failure'
evidence:
  quality_rating: A
  n_studies: 39
  primary_citation: 'A Hashim et al. 2021. Community-Based Assessment and Treatment
    of Hepatitis C Virus-Related Liver Disease, Injecting Drug and Alcohol Use Amongst
    People Who Are Homeless: A Systematic Review and Meta-Analysis. The International
    journal on drug policy.'
  supporting_citations: []
description: Injecting drug use increases liver disease hospitalization primarily
  through hepatitis C virus transmission via contaminated injection equipment. In
  populations with high injecting drug use prevalence, HCV seroprevalence reaches
  20%, leading to progressive liver fibrosis and cirrhosis (F4 fibrosis prevalence
  7-16%). The pathway is exacerbated by concurrent alcohol use and barriers to HCV
  treatment access, particularly among marginalized populations.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 0.2
    type: prevalence
    ci_lower: 0.12
    ci_upper: 0.3
  p_value: null
  sample_size: 13918
moderators:
- name: alcohol_use
  direction: strengthens
  strength: strong
  description: Alcohol use prevalence of 59% (95% CI 20%-92%) in homeless populations
    accelerates liver disease progression in those with HCV infection
- name: housing_status
  direction: strengthens
  strength: moderate
  description: Homelessness creates barriers to HCV treatment access, with community-based
    interventions significantly improving linkage to care (p=0.04) and treatment outcomes
- name: access_to_treatment
  direction: weakens
  strength: strong
  description: Direct-acting antiviral treatment achieves 82-92% sustained virological
    response rates, preventing progression to advanced liver disease when accessible
